Scarce literature about fecal liquid biopsy and Kras mutations originating from the cells of pancreatic adenocarcinomas and from cells shed by abnormal pancreatic duct epithelium detected in the stool is now available [151]. This evidence concerns the gene KRAS and pancreatic adenocarcinoma.